Stock Rich List
Nasdaq: ALNY

Alnylam Pharmaceuticals insiders

The officers, directors and 10% owners of Alnylam Pharmaceuticals, Inc. who hold the most stock, valued at the live ALNY price.

$147.82
ALNY today −$1.6M (−1.06%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
10
Their ALNY stock
$109M
Market value
$19.80B
Held by ranked insiders
0.55%

Insiders by value of ALNY holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Phillip A. SharpDirector266,899$39.5M0.20%2946th
2John MaraganoreChief Executive Officer230,796$34.1M0.17%1983rd
3Yvonne GreenstreetChief Executive Officer85,209$12.6M<0.1%7178th
4Jeffrey Poulton V.EVP, Chief Financial Officer61,862$9.1M<0.1%9374th
5Tolga TangulerEVP, Chief Commercial Officer34,297$5.1M<0.1%14320th
6David E. I. PyottDirector33,262$4.9M<0.1%9651st
7Akshay VaishnawPresident23,289$3.4M<0.1%3321st
8Steven M. PaulDirector1,000$148K<0.1%3876th
9Carolyn R. BertozziDirector775$115K<0.1%3553rd
10Stuart A. ArbuckleDirector671$99K<0.1%3307th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Alnylam Pharmaceuticals; see each profile for the filing.